Диссертация (Влияние синтетических ноотропных средств на активность металлозависимых протеиназ), страница 18

– 1988. – Vol. 70, N 1. – P. 57 –64.169. MacCumber, M.W. Carboxypeptidase E (enkephalin convertase): mRNAdistribution in rat brain by in situ hybridization /M.W.MacCumber,S.H.Snyder, C.A.Ross // The Journal of neuroscience: the official journal of theSociety for Neuroscience.

– 1990. – Vol. 10, N 8. – P. 2850 – 2860.170. Mackin, R.B. Charasterization of an islet carboxypeptidase B involved inprohormone processing /R.B.Mackin, B.D.Noe // Endocrinology. – 1987. –Vol. 120, N 2. – P. 457 – 468.171. Magnan, J. Theinteractionof[MET5] enkephalinand[LEU5]enkephalin sequences, extended at the C-terminus, with the mu-, deltaand kappa-binding sites in the guinea-pig brain /J.Magnan, S. J.Paterson, H.W.Kosterlitz // Life sciences. – 1982. – N 31. – P. 1359 – 1361.172. Malykh, A.G. Piracetam and piracetam-like drugs: from basic science tonovel clinical applications to CNS disorders /A.G.Malykh, M.R.Sadaie //Drugs. – 2010. – Vol. 70, N3. – P.

287 – 312.173. Manser, E. Human carboxypeptidase E., Isolation and characterization of thecDNA, sequence conservation, expression and processing in vitro /E.Manser,D.Fernandez, L.Loo, P.Y.Goh, C.Monfries, C.Hall, L.Lim // The Biochemicaljournal. – 1990. – 267, N 2. – P. 517 – 525.174. Marubio, L.M.

Impaired passive avoidance learning in mice lacking centralneuronalnicotinicacetylcholinereceptors /L.M.Marubio, R.Paylor //Neuroscience. – 2004. –N. 129. – P. 575 – 582.175. Mathews, K. P. Familial carboxypeptidase N deficiency /K.P.Mathews,P.M.Pan, N.J.Gardner, T.E.Hugli // Annals of internal medicine. – 1980. – N.93. – P.

443 – 445.176. Matthews,K.W.Carboxypeptidase N:apleiotropic regulator ofinflammation /K.W.Matthews, S.L.Mueller-Ortiz, R.A.Wetsel // Molecularimmunology. – 2004. – N. 40. – P. 785 – 793.114177. McGwire, G. B. Extracellular conversion of epidermal growth factor (EGF)to des Arg53-EGF by carboxypeptidase M /G.B.McGwire, R.A.Skidgel // TheJournal of biological chemistry. – 1995.

– N. 270. – P. 17154 – 17158.178. Mentein, R. Proteases involved in the metabolism of angiotensin II,bradykinin, calcitonin gene-related peptide (CGRP), and neuropeptide Y byvascular smooth muscle cells /R.Mentein, T.Roos // Peptides. – 1996. – Vol.17, N.

4. – P. 709 – 720.179. Millan,M.J.Cognitivedysfunctioninpsychiatricdis-orders:Characteristics, causes and the quest for improved therapy /M.J.Millan,Y.Agid, M.Brune, E.T.Bullmore, C.S.Carter, N.S.Clayton, R.Connor, S.Davis,B.Deakin, R.J.DeRubeis, B.Dubois, M.A.Geyer, G.M.Goodwin, P.Gorwood,T.M.Jay, M.Joels, I.M.Mansuy, A.Meyer-Lindenberg, D.Murphy, E.Rolls,B.Saletu, M.Spedding, J.Sweeney, M.Whittington, L.J.Young // Naturereviews. Drug discovery. – 2012. – N. 11. – P. 141 – 168.180. Mondadore, C. The pharmacology of the nootropics; new insights and newquestions /C.Mondadore // Behavioral Brain Research.

– 1993. – Vol. 59. – P.1 – 9.181. Mondadori, C. Elevated corticosteroid levels block memory-improvingeffects of nootropics and cholinomimetics /C.Mondadori, T.Ducret, A.Hauesler// Psychopharmacology. – 1992. – Vol. 108. – P. 11 – 15.182. Moriau, M. Platelet anti-aggregant and rheological properties of piracetam.A Pharmacodynamics study in normal subjects /M.Moriau, L.Crasborn,E.Lavenne-Pardonge, R.Von Frenckell, C.Col-Debeys // ArzneimittelForschung.

– 1993. – Vol. 43, N 2. – P. 110 – 118.183. Moriau, M. The treatment of severe or recurrent deep venous thrombosis.Beneficial effect of the co-administration of antiplatelet agents with or withoutrheological effects, and anticoagulants /M.Moriau, E.Lavenne-Pardonge,L.Crasborn, R.Von Frenckell, C.Col-Debeys// Thrombosis Research. – 1995. –Vol.

78, N 6. – P. 469 – 482.115184. Müller W.E. Piracetam: novelty in a unique mode of action /W.E.Müller,G.P.Eckert, A.Eckert // Pharmacopsychiatry. – 1999. – N 32, Suppl 1. – P. 2 –9.185. Nalamachu, S.R. Regulation of carboxypeptidase E - effect of Ca2+ onenzyme-activity and stability /S.R.Nalamachu, L.X.Song, L.D.Fricker // TheJournal of biological chemistry. – 1994. – Vol.

269, N 15. – P. 11192 – 11195.186. Narahashi, T. Mechanisms of action of cognitive enhancers onneuroreceptors /T.Narahashi, S.Moriguchi, X.Zhao, W.Marszalec, J.Z.Yeh //Biological & pharmaceutical bulletin. – 2004. – N 27. – P. 1701 – 1706.187. Nehlig, A.Is caffeine a cognitive enhancer? / A.Nehlig // Journal ofAlzheimer's disease: JAD.

– 2010. – N 20, Suppl. 1. – P. 85–94.188. Nickolson, V.J. Effect of the acquisition-enhancing drug piracetam on ratcerebralenergymethamphetaminemetabolism.Comparison/V.J.Nickolson,withO.L.Wolthuisnaftidrofuryl//andBiochemicalpharmacology. – 1976. – Vol. 25, N 20. – P. 2241 – 2244.189. Nootropil. Arzneimittel-Kompendium der Schweiz. 2013-09-12.

Retrieved2013-10-27.Режимдоступа:http://compendium.ch/mpro/mnr/3048/html/de190. O'Neill, M.J. AMPA receptor potentiators for the treatment of CNSdisorders /M.J.O'Neill, D.Bleakman, D.M.Zimmerman, E.S.Nisenbaum //Current drug targets. CNS and neurological disorders. – 2004. – Vol.

3, N 3. –P. 181 – 194.191. Ortego, J. Identification of a neuropeptide and neuropeptide processingenzymes in aqueous humor confers neuroendocrine features to the humanocular ciliary epithelium /J.Ortego, J.Escribano, J.Crabb, M.Coca Prados //Journal of neurochemistry. – 1996. – Vol. 66, N 2. – P. 787 – 796.192. Oshima, G. Subunits of human plasma carboxypeptidase N (kininase I;anaphylatoxin inactivator) /G.Oshima, J.Kato, E.G.Erdös // Biochimica etbiophysica acta. – 1974. – Vol.

365. – P. 344 – 348.116193. Oshima, G. Plasma carboxypeptidase N, subunits and characteristics/G.Oshima, J.Kato, E.G.Erdös // Archives of biochemistry and biophysics. –1975. – N 170. – P. 132 – 138.194. Ostrovskaya, R.U. The novel substituted acylprolinecontaining dipeptide,GVS-111, promotes the restoration of learning and memory impaired bybilateral frontal lobectomy in rats /R.U.Ostrovskaya, G.A.Romanova,S.S.Trofimov, T.A.Gudasheva, T.A.Voronina, J.A.Halikas, S.B.Seredenin //Behavioural pharmacology.

– 1997. – Vol. 8. – P. 261 – 268.195. Oyarce, A.M. Dopaminergic regulation of secretory granule associatedproteins in rat intermediate pituitary /A.M.Oyarce, T.A.Hand, R.E.Mains,B.A.Eipper // Journal of neurochemistry. – 1996. – Vol. 67, N 1. – P.

229 –241.196. Parkinson, D. Carboxypeptidase H in bovine pituitary gland: soluble formsare not processed at the C-terminus /D.Parkinson // Molecular and cellularendocrinology. – 1992. – Vol. 86, N 3. – P. 221 – 233.197. Parkinson, D. Two soluble forms of bovine carboxypeptidase H havedifferent NH2-terminal sequences /D.Parkinson // The Journal of biologicalchemistry. – 1990. – Vol.

265, N 28. – P. 17101 – 17105.198. Pelsman, A. GVS-111 prevents oxidative damage and apoptosis in normaland Down,s syndrome human cortical neurons / A.Pelsman, C.Hoyo-Vadillo,T.A.Gudasheva, S.B.Seredenin, R.U.Ostrovskaya, J.Busciglio // Internationaljournal of developmental neuroscience: the official journal of the InternationalSociety for Developmental Neuroscience. – 2003.

– Vol. 803. – P. 1 – 8.199. Perloff, M.D. Reduced levels of substance P in the brains ofCpe(Fat)/Cpe(Fat) Mice /M.D.Perloff, R.M.Kream, M.C. Beinfeld // Peptides.– 1998. – Vol. 19, N 6. – P. 1115 – 1117.200. Pilch, H. Piracetam elevates muscarinic cholinoreceptor density in thefrontal cortex of aged but not of young mice /H.Pilch, W.F.Muller //Psychopharmacology. – 1988. – Vol. 94. – P. 74 – 48.117201. Piracetam Material Safety Sheet. Spectrum Laboratory Products, Inc. Режимдоступа: https://www.spectrumchemical.com/MSDS/P3941.PDF202. Plow, E.F. The plasma carboxypeptidases and the regulation of theplasminogen system /E.F.Plow, K.Allampallam, A.Redlitz // Trends incardiovascular medicine.

– 1997. – Vol. 7. – P. 71 – 75.203. Plummer, T.H.J. Human plasma carboxypeptidase N. Isolation andcharacterization /T.H.J.Plummer, M.Y.Hurwitz // The Journal of biologicalchemistry. – 1978. – N 253. – 3907 – 3912.204. Quagraine, M.O. Plasmin alters the activity and quaternary structure ofhuman plasma carboxypeptidase N /M.O.Quagraine, F.Tan, H.Tamei,E.G.Erdös, R.A.Skidgel // The Biochemical journal. – 2005. – Vol. 388, Pt. 1.– P. 81 – 91.205.

Ranby, M. Studies on the kinetics of plasminogen activation by tissueplasminogen activator /M.Ranby // Biochimica et biophysica acta. – 1982. –Vol. 704. P. 461 – 469.206. Redlitz, A. Plasma carboxypeptidases as regulators of the plasminogensystem /A.Redlitz, A.K.Tan, D.L.Eaton, E.F.Plow // The Journal of clinicalinvestigation. – 1995, N 96.

– P. 2534 – 2538.207. Rehni, A.K.Role of ATP-sensitive potassium channels in the piracetaminduced blockade of opioid effects /A.K.Rehni, N.Singh, S.Jindal // IndianJournal of Experimental Biology. – 2007. – Vol. 45. – P. 1050-1054.208. Rodriguez, C. Rat preprocarboxypeptidase H. Cloning, characterization, andsequence of the cDNA and regulation of the mRNA by corticotropin releasingfactor /C.Rodriguez, K.A.Brayton, M.Brownstein, J.E.Dixon // The Journal ofbiological chemistry. – 1989. – Vol. 264, N 10. – P. 5988 – 5995.209.

Rossier, J. Radiometric assay for carboxypeptidase H (EC 3.4.17.10) andother carboxypeptidase B-like enzymes /J.Rossier, E.Barres, J.C.Hutton,R.J.Ricknell // Analytical biochemistry. – 1989. – Vol. 178, N 1. – P. 27 – 31.210. Rouille,Y.Partialpharmacologicallyconversionactiveofvasopressinvasopressinyl-Gly-Lys-Argthroughsecretoryintogranule118carboxypeptidase E and alpha-amidating processing enzymes /Y.Rouille,J.Chauvet, R.Acher // Biochemistry international. – 1992. – Vol. 26, N 4. –P.739 – 746.211. Ryoichi, K.

Hydrolysis of neo-kyotophin (Thr-Ser-Lys-Tyr-Arg) and[met]enkephalin - Arg6-Phe7 by ACE from moncey brain /K.Ryoichi, S.Reiko,K.Takshi, T.Hazato // Biochemical pharmacology. – 1986. – Vol. 35, N 24. –P. 4499 – 4503.212. Samotrueva, M.A. Experimental learning of dose-related influence ofphenotropilonI.N.Tyurenkov,humorallinkS.A.Luzhnova,ofimmunogenesisM.M.Magomedov,/M.A.Samotrueva,N.R.Kuleshevskaya,T.K.Serezhnikova // European Journal of Natural History.

– 2010. – N 3. – P.61 – 62.213. Schlamp, C.L. Light and dark cause a shift in the spatial expression of aneuropeptide processing enzyme in the rat retina /C.L.Schlamp, R.W.Nickells// The Journal of neuroscience: the official journal of the Society forNeuroscience. – 1996. – Vol. 16, N 7. – P. 2164 – 2171.214.

Schmieder, R.E. Effects of angiotensin converting enzyme inhibitor on renalheamodynamicsduringmentalstress/R.E.Schmieder,H.P.Schobel,C.E.Gatzka, W.Hauser, P.Dominik, J.F.Mann, F.C.Luft // Journal ofhypertension. – 1996. – Vol. 14, N 10. – P. 1201 – 1207.215. Shen, Y. The role of neuropeptides in learning and memory: possiblemechanisms /Y.Shen, R.Li // Medical hypotheses.